400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / Microtubule/Tubulin / DM3
CAS No.: 796073-54-6
Synonyms: Maytansinoid DM3
DM3 is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03577483 | Parkinson Disease ... more >> MSA - Multiple System Atrophy Collapse << | Not Applicable | Recruiting | June 1, 2019 | France ... more >> Centre Hospitalier Universitaire de Bordeaux Recruiting Bordeaux, France, 33000 Contact: Wassilios MEISSNER, MD, PhD +335 57 82 12 53 wassilios.meissner@chu-bordeaux.fr Contact: Sandrine VILLARS +335 57 82 12 53 sandrine.villars@chu-bordeaux.fr Centre Hospitalier Universitaire de Toulouse Not yet recruiting Toulouse, France, 31000 Contact: Anne PAVY-LE-TRAON, MD,PhD +335 61 77 95 19 pavy-letraon.a@chu-toulouse.fr Collapse << |
NCT00593957 | Rett Syndrome | Phase 2 | Terminated(Study changed to a ... more >>placebo controlled trial of dextromethorphan) Collapse << | - | United States, Maryland ... more >> Kennedy Krieger Institute/Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21205 Collapse << |
NCT02835053 | - | - | Completed | - | Canada, Ontario ... more >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1Y 4E9 Collapse << |
实验方案
技术信息
CAS号 | 796073-54-6 | 储存条件 |
|
|
分子式 | C37H52ClN3O10S | 运输 | 蓝冰 | |
分子量 | 766.34 | 别名 | Maytansinoid DM3 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03577483 | Parkinson Disease ... more >> MSA - Multiple System Atrophy Collapse << | Not Applicable | Recruiting | June 1, 2019 | France ... more >> Centre Hospitalier Universitaire de Bordeaux Recruiting Bordeaux, France, 33000 Contact: Wassilios MEISSNER, MD, PhD +335 57 82 12 53 wassilios.meissner@chu-bordeaux.fr Contact: Sandrine VILLARS +335 57 82 12 53 sandrine.villars@chu-bordeaux.fr Centre Hospitalier Universitaire de Toulouse Not yet recruiting Toulouse, France, 31000 Contact: Anne PAVY-LE-TRAON, MD,PhD +335 61 77 95 19 pavy-letraon.a@chu-toulouse.fr Collapse << |
NCT00593957 | Rett Syndrome | Phase 2 | Terminated(Study changed to a ... more >>placebo controlled trial of dextromethorphan) Collapse << | - | United States, Maryland ... more >> Kennedy Krieger Institute/Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21205 Collapse << |
NCT02835053 | - | - | Completed | - | Canada, Ontario ... more >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1Y 4E9 Collapse << |
NCT00593957 | - | - | Terminated(Study changed to a ... more >>placebo controlled trial of dextromethorphan) Collapse << | - | - |
NCT01767831 | - | - | Terminated(study team will rev... more >>iew the collected data and make any necessary changes to the educational tool.) Collapse << | - | United States, Virginia ... more >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22904 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网